Bridge Research Consortium
Bridging Immune Research and Public Understanding
Together with the Bridge Research Consortium (BRC), we’re co-creating training, resources, and public-facing content that help Canadians understand the science behind immune-based innovations (e.g. vaccines and other RNA therapies) through clear communication, co-created content, and engaging public programming.
Collaborative Content
RNA Unwrapped
mRNA Is Natural TBD
3 Facts About RNA TBD
RNA Therapeutics are more than vaccines TBD
Sample Text
Meet the Innovators (TBD)
Behind every study, dataset, and breakthrough are real people asking tough questions and testing new ideas. In this rotating spotlight, we highlight researchers and innovators whose work is helping move science forward.
About Bridge Research Consortium
The Bridge Research Consortium (BRC) is a multidisciplinary team of leading social sciences and humanities scholars, along with public health and biomedical experts, from across Canada and beyond.
The BRC is one of several projects funded as part of Canada’s Immuno-Engineering and Biomanufacturing Hub (CIEBH).